Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Chapelin
M. Chapelin
European Medicines Agency
Medicine
Immunology
Pharmacology
Authorization
Market access
4
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Early market access of cancer drugs in the EU
2016
Annals of Oncology
J. Martinalbo
D. Bowen
J. Camarero
M. Chapelin
Pierre Demolis
P. Foggi
Bertil Jonsson
J. Llinares
Alexandre Moreau
Daniel O’Connor
J Oliveira
Spiros Vamvakas
Francesco Pignatti
Show All
Source
Cite
Save
Citations (48)
Anticancer drugs, European Marketing Authorisation. Whats New?
2005
Oncologie
P. Démolis
Ahn Do
G. Lebbe
Alain Moreau
V. Petrov-Sanchez
M. Chapelin
Show All
Source
Cite
Save
Citations (0)
Statut des anti-cancéreux, AMM européenne, quoi de neuf ?
2005
Oncologie
P. Démolis
Ahn Do
G. Lebbe
Alain Moreau
V. Petrov-Sanchez
M. Chapelin
Show All
Source
Cite
Save
Citations (1)
Statut des anti-cancreux, AMM europenne, quoi de neuf ?
2005
Oncologie
P. Démolis
Ahn Do
G. Lebbe
Alain Moreau
V. Petrov-Sanchez
M. Chapelin
Show All
Source
Cite
Save
Citations (0)
1